My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Catalent, Inc. Common Stock (NY:CTLT)

63.48 UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Catalent, Inc. Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Recap: Catalent Q4 Earnings ↗

August 29, 2022

Catalent (NYSE:CTLT) reported its Q4 earnings results on Monday, August 29, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Fear & Greed Index Moves To 'Fear' Zone As Dow Dips Over 1,000 Points Following Powell's Speech ↗

August 29, 2022

The CNN Money Fear and Greed index moved to the "fear" zone after the Dow Jones dipped more than 1,000 points on Friday following Powell’s comments. Fed Chair Jerome Powell, at the Jackson Hole...

Via Benzinga

Dow, Nasdaq Futures Lower Following Friday's Sell-Off; US Dollar Surges To 20-Year High ↗

August 29, 2022

Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled more than 1,000 points in the previous session following speech from Federal Reserve Chairman...

Via Benzinga

Earnings Scheduled For August 29, 2022 ↗

August 29, 2022

Companies Reporting Before The Bell • NAPCO Security (NASDAQ:NSSC) is expected to report earnings for its fourth quarter.

Via Benzinga

Catalent-Repligen Merger 'Seems Unlikely,' This Analyst Says ↗

August 12, 2022

Via Benzinga

Catalent's New Acquisition will Expand High-Potent Capabilities, Oral Manufacturing Capacity: Report ↗

August 10, 2022

Via Benzinga

Catalent Shares Jump As Investors Cheer Revised, Better Than Expected FY22 Outlook ↗

May 03, 2022

Via Benzinga

Catalent, Pinduoduo And 3 Stocks To Watch Heading Into Monday ↗

August 29, 2022

With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Bitcoin Tumbles Below This Major Level Following Powell's Remarks; Here Are The Top Crypto Movers For Monday ↗

August 29, 2022

Bitcoin (CRYPTO: BTC), the world’s most valued cryptocurrency, recorded a massive sell-off, with price for the cryptocurrency falling below the $20,000 level this morning following comments from US...

Via Benzinga

Catalent's Earnings: A Preview ↗

August 26, 2022

Catalent (NYSE:CTLT) is set to give its latest quarterly earnings report on Monday, 2022-08-29. Here's what investors need to know before the announcement. Analysts estimate that Catalent will report...

Via Benzinga

Is Novavax Stock A Buy After Omicron Results Impress Two FDA Experts? ↗

July 06, 2022

The FDA is reviewing additional manufacturing data before making a decision.

Via Investor's Business Daily

Quant Ratings Updated on 75 Stocks ↗

May 26, 2022

I decided to revise my Portfolio Grader recommendations for 75 big blue chips -- of those 75, 24 stocks were updated to a buy.

Via InvestorPlace

Recap: Catalent Q3 Earnings ↗

May 03, 2022

Catalent (NYSE:CTLT) reported its Q3 earnings results on Tuesday, May 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Erytech Pharma Are Shares Moving Higher Today ↗

April 25, 2022

Via Benzinga

Catalent's Q2 Earnings Beat Street View, Lifts FY22 Guidance ↗

February 01, 2022

Catalent Inc (NYSE: CTLT) has reported Q2 FY22 sales of $1.

Via Benzinga

Morgan Stanley Maintains Overweight Rating for Catalent: Here's What You Need To Know ↗

May 04, 2022

Morgan Stanley has decided to maintain its Overweight rating of Catalent (NYSE:CTLT) and lower its price target from $145.00 to $132.00. Shares of Catalent are trading up 1.11% over the last 24 hours,...

Via Benzinga

80 Biggest Movers From Yesterday ↗

May 04, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to...

Via Benzinga

Expert Ratings For Catalent ↗

January 27, 2022

Analysts have provided the following ratings for Catalent (NYSE:CTLT) within the last quarter:

Via Benzinga

Stocks Stage Midday Rally as Bond Yields Cool ↗

May 03, 2022

Stocks are rallying this afternoon, as investors prepare for the Federal Reserve's interest rate decision, which is due out tomorrow.

Via Talk Markets

41 Stocks Moving In Tuesday's Mid-Day Session ↗

May 03, 2022

Gainers SoundHound AI, Inc. (NASDAQ: SOUN) shares jumped 47.4% to $16.13. The company recently completed a SPAC merger deal last week and began trading on Thursday. Sonoma...

Via Benzinga

How To Attend Catalent Q3 2022 Earnings Conference Call ↗

April 21, 2022

Catalent (NYSE:CTLT) will host a conference call at 08:15 AM ET on May 3, 2022, to discuss Q3 2022 earnings results. How to Attend Catalent (CTLT) Conference Call Follow this link to access the live...

Via Benzinga

24 Biggest Movers From Yesterday ↗

April 13, 2022

Gainers Vertical Aerospace Ltd. (NYSE: EVTL) Shares hiked 30.93% to close at $9.82 on Tuesday after Deutsche Bank initiated coverage of the stock. Peabody Energy Corporation (...

Via Benzinga

Markets Fall As Investors Weigh March CPI Report ↗

April 12, 2022

U.S. indices sold off to close Tuesday’s session following earlier strength. Investors reacted to the March CPI report and continue to assess Fed rate hike concerns. While...

Via Benzinga

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout ↗

March 22, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Novo Nordisk Doubles 2025 Sales Target On Strong Wegovy Demand ↗

March 03, 2022

Novo Nordisk A/S (NYSE: NVO) has more than doubled its target for sales of obesity drugs by 2025 after overwhelming demand for its new Wegovy drug. Novo Nordisk aims to...

Via Benzinga

Executives Sell More Than $210M Of 5 Stocks ↗

February 09, 2022

Spanish stocks traded higher this morning, with the IBEX 35 Index surging to the strongest level in over two weeks. Investors, meanwhile, focused on some notable insider trades....

Via Benzinga

The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program ↗

February 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

A Bearish Sign Appears On Catalent's Chart ↗

January 31, 2022

If history is any guide, there may be trouble ahead for shares of Catalent (NYSE:CTLT). A so-called "death cross" has formed on its chart and, not surprisingly, this could be...

Via Benzinga

The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News ↗

January 31, 2022

The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.

Via Benzinga

This Tattooed, Cowboy-Boot-Wearing Top CEO Refuses To Go Clean Cut ↗

January 20, 2022

John Chiminski knows he doesn't fit the traditional image of a corporate bigwig. And the Catalent CEO is not about to change.

Via Investor's Business Daily

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.